Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now
Read now
Articles from other publishers (3)
Lilit Karapetyan, Uzoma K Iheagwara, Adam C Olson, Steven J Chmura, Heath K Skinner & Jason J Luke. (2023) Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations. JNCI: Journal of the National Cancer Institute 115:11, pages 1278-1293.
Crossref
Crossref
Julia Katharina Schwarze, Xenia Geeraerts, Sandra Tuyaerts & Bart Neyns. (2023) Current “state of the art” on dendritic cell-based cancer vaccines in melanoma. Current Opinion in Oncology 35:2, pages 87-93.
Crossref
Crossref
Cristina Bergamaschi, Vasiliki Stravokefalou, Dimitris Stellas, Sevasti Karaliota, Barbara K. Felber & George N. Pavlakis. (2021) Heterodimeric IL-15 in Cancer Immunotherapy. Cancers 13:4, pages 837.
Crossref
Crossref